A Randomized Controlled Trial Comparing Blood Pressure Reduction in Hyperacute Phase of Spontaneous Intracerebral Hemorrhage by Continuous Nicardipine Infusion with or without a Preceding Nicardipine Bolus dose

There were no significant differences in baseline SBP between the two groups, but the bolus group achieved the target SBP of 180 mmHg more rapidly. No patients in either group experienced neurological deterioration during the first hour of treatment, and the infusion dosages of Nicardipine at 1 hour were not statistically significantly different in both groups.